December 2005

Stephen F. Olmstead, M.D. has been named Chief Science Officer of ProThera® , Inc. With more than 25 years of experience in clinical trials, registries and basic research, Dr. Olmstead will be responsible for directing the company's technical services and clinical trials.

“We are very excited that Dr. Olmstead has joined our team,” says Janet Ralston, Vice President of Marketing. “We are very confident that his skills and experience will be a great contribution to ProThera's success.”

Dr. Olmstead has long been an advocate of rigorous scientific research on complementary medical therapies. Having graduated from the University of New Mexico with distinction in biology and chemistry, his academic honors include Phi Beta Kappa and Alpha Omega Alpha. Dr. Olmstead earned his residency at Harvard Medical School, Massachusetts General Hospital.

For many years, Dr. Olmstead spent his career as the Clinical Assistant Professor in Medicine at the University of Washington Medical School in Seattle. He also served as advisor to the King County Natural Medicine Clinic during its inception and was a consultant to the Office of Alternative Medicine after it was first established at the National Institutes of Health. Dr. Olmstead is board certified in both internal medicine and cardiovascular diseases.

Dr. Olmstead is enthusiastic about starting his new career with ProThera. He stated, “I am honored to join ProThera. This company is known for the excellence of its client services and high quality of its products.  I look forward to contributing to research on the fundamental and clinical actions of vitamins, herbals, and nutraceuticals.”